NCT03128723 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Muizzuddin N, Marenus KD, Maes DH
Factors defining sensitive skin and its treatment. Am J Contact Dermat. 1998 Sep;9(3):170-5.
Sagransky M, Yentzer BA, Feldman SR
Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert Opin Pharmacother. 2009 Oct;10(15):2555-62. doi: 10.1517/14656560903277228. Review.
Willis CM, Shaw S, De Lacharrière O, Baverel M, Reiche L, Jourdain R, Bastien P, Wilkinson JD
Sensitive skin: an epidemiological study. Br J Dermatol. 2001 Aug;145(2):258-63.

A Single Center Clinical Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris

Clinical trial NCT03128723 - References